ABCC1 and neoplasm: Where prior studies in erythrocytes have suggested that deoxycholic acid has an IC50 of 16 μM for inhibition of fluorescent substrate efflux, we have observed IC50’s ~10-fold higher for inhibition of ABCC1-mediated doxorubicin efflux from tumour cells.